Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas P Restifo

Showing results (71-80 of 260) with videos related to

Pageof 26
Sort By:
Cancer Immunology Research|February 10, 2015
Microbiota modulation of myeloid cells in cancer therapyRomina S Goldszmid, Amiran Dzutsev, Sophie Viaud, et al.
JCI Insight|May 17, 2019
An effective mouse model for adoptive cancer immunotherapy targeting neoantigensKen-Ichi Hanada, Zhiya Yu, Gabrielle R Chappell, et al.
Trends in Immunology|January 26, 2005
Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapyChristopher A Klebanoff, Hung T Khong, Paul A Antony, et al.
The Prostate|October 19, 2002
Antigen-specific tumor vaccine efficacy in vivo against prostate cancer with low class I MHC requires competent class II MHCYilin C Neeley, Kevin T McDonagh, Willem W Overwijk, et al.
Cancer Research|May 2, 2013
Simultaneous targeting of tumor antigens and the tumor vasculature using T lymphocyte transfer synergize to induce regression of established tumors in miceDhanalakshmi Chinnasamy, Eric Tran, Zhiya Yu, et al.
European Journal of Immunology|October 12, 2013
Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cellsSarah E Church, Shawn M Jensen, Paul A Antony, et al.
Nature Reviews. Cancer|March 21, 2008
Adoptive cell transfer: a clinical path to effective cancer immunotherapySteven A Rosenberg, Nicholas P Restifo, James C Yang, et al.
Cancer Research|July 16, 2010
Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancerRajeev K Shrimali, Zhiya Yu, Marc R Theoret, et al.
Cancer Immunology Research|December 25, 2015
Identification of T-cell Receptors Targeting KRAS-Mutated Human TumorsQiong J Wang, Zhiya Yu, Kayla Griffith, et al.
Blood|June 30, 2009
Programming tumor-reactive effector memory CD8+ T cells in vitro obviates the requirement for in vivo vaccinationChristopher A Klebanoff, Zhiya Yu, Leroy N Hwang, et al.
Pageof 26

Showing results (71-80 of 260) with videos related to

Sort By:
Pageof 26
Cancer Immunology Research|February 10, 2015
Microbiota modulation of myeloid cells in cancer therapyRomina S Goldszmid, Amiran Dzutsev, Sophie Viaud, et al.
JCI Insight|May 17, 2019
An effective mouse model for adoptive cancer immunotherapy targeting neoantigensKen-Ichi Hanada, Zhiya Yu, Gabrielle R Chappell, et al.
Trends in Immunology|January 26, 2005
Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapyChristopher A Klebanoff, Hung T Khong, Paul A Antony, et al.
The Prostate|October 19, 2002
Antigen-specific tumor vaccine efficacy in vivo against prostate cancer with low class I MHC requires competent class II MHCYilin C Neeley, Kevin T McDonagh, Willem W Overwijk, et al.
Cancer Research|May 2, 2013
Simultaneous targeting of tumor antigens and the tumor vasculature using T lymphocyte transfer synergize to induce regression of established tumors in miceDhanalakshmi Chinnasamy, Eric Tran, Zhiya Yu, et al.
European Journal of Immunology|October 12, 2013
Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cellsSarah E Church, Shawn M Jensen, Paul A Antony, et al.
Nature Reviews. Cancer|March 21, 2008
Adoptive cell transfer: a clinical path to effective cancer immunotherapySteven A Rosenberg, Nicholas P Restifo, James C Yang, et al.
Cancer Research|July 16, 2010
Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancerRajeev K Shrimali, Zhiya Yu, Marc R Theoret, et al.
Cancer Immunology Research|December 25, 2015
Identification of T-cell Receptors Targeting KRAS-Mutated Human TumorsQiong J Wang, Zhiya Yu, Kayla Griffith, et al.
Blood|June 30, 2009
Programming tumor-reactive effector memory CD8+ T cells in vitro obviates the requirement for in vivo vaccinationChristopher A Klebanoff, Zhiya Yu, Leroy N Hwang, et al.
Pageof 26